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Macrophage-enriched peritoneal exudate cells from mice infected with Myco-
bacterium bovis BCG, macrophage-like tumor cells (PU 5-1.8), and peritoneal
macrophages propagated in vitro with macrophage growth factor released tumor-
icidal activity into the culture medium within 2 to 3 h after stimulation with
nanogram quantities of bacterial lipopolysaccharide. The cytotoxic activities from
each of the macrophage culture supernatants eluted from diethylaminoethyl-
Sephacel columns at a sodium chloride concentration of 200 mM exhibited a
molecular weight of 50,000 to 60,000 as estimated by gel filtration, were stable at
560C for 30 min, and were active at a pH range of 6 to 10. A rabbit antiserum
directed against serum-derived cytotoxic activity (tumor-necrotizing factor) from
BCG-infected and lipopolysaccharide-challenged mice inhibited all of the cyto-
toxic activities generated in vitro. This suggests that the macrophage-derived
cytotoxins are identical with serum-derived cytotoxic factor, which further implies
that the macrophage is the cellular source of tumor-necrotizing factor.
Activation of macrophages has been associ-
ated with the production of a number of soluble
factors. One group of macrophage mediators in-
cludes substances that are cytotoxic for tumor
cells (1-3, 5, 6, 8, 10, 16, 18, 19, 24, 27, 28, 31). A
putative macrophage-derived factor reported to
be tumoricidal in vivo as well as in vitro is
tumor-necrotizing factor (TNF) (4). TNF, which
is found in the serum of mice infected with
Mycobacterium bovis BCG after injection of
lipopolysaccharide (LPS), induces tumor necro-
sis in recipient animals (4) and is cytotoxic for a
variety of tumor target cells in vitro (4, 9).
In earlier communications we described the
mode of in vivo production and characterization
of a cytotoxic factor for cultured tumor cells
which is probably identical to TNF (13, 14). The
present study was undertaken to determine the
cellular source of the serum factor. Therefore,
we investigated the capacity of various cell types
in vitro to release cytotoxins with characteristics
similar to those of the serum-derived tumor
cytotoxic factor. Macrophage-enriched cell pop-
ulations from BCG-infected mice, macrophage-
like tumor cells (PU 5-1.8) (20), and peritoneal
macrophages propagated with macrophage
growth factor (30) release cytotoxic activity
when stimulated in vitro with LPS. The condi-
tions and kinetics for cytotoxin release were
determined, and the cytotoxic activities ob-
tained in culture supernatants were compared
with those ofthe serum-derived cytotoxic factor.
t Present address: Laboratory of Immunobiology, National
Cancer Institute, Bethesda, MD 20205.
MATERIALS AND METHODS
Mice. Female C3H/HeN mice 6 to 12 weeks of age
were obtained from the Division of Research Services,
National Institutes of Health, Bethesda, Md.
LPS. Escherichia coli K235 LPS was prepared by
the phenol-water extraction method of McIntire et al.
(15).
Preparation of cytotoxic serum. Mice were in-
jected intravenously with 2 x 10e colony-forming units
of living M. bovis strain BCG (Phipps substrain TMC
no. 1029, Trudeau Mycobacterial Collection, Saranac
Lake, N.Y.) and then injected intravenously 14 days
later with 10,ug ofLPS. Two hours after LPS injection,
animals were exsanguinated and the serum was pre-
pared. Control serum was obtained from LPS-injected
normal mice in a similar manner. All sera were stored
at -20°C until used.
Cytotoxicity assay. Tumor cells (mouse L 929,
American Type Culture Collection) at 4 x 103 cells per
6.4-mm culture well (Costar 96, Cambridge, Mass.)
were labeled in 0.1 ml of Eagle minimal essential
medium (MEM) with 25 mM HEPES (N-2-hydroxy-
ethylpiperazine-N'-2-ethanesulfonic acid) buffer, 5%
heat-inactivated fetal calf serum (FCS), and 0.5 fiCi of
[3H]TdR ([methyl-3H]thymidine; specific activity, 6.7
Ci/mmol; New England Nuclear, Boston, Mass.) per
ml for 18 to 24 h. Tumor cell monolayers were washed
twice after labeling and were incubated in dilutions of
cytotoxic serum or supernatants in 0.2 ml of Dulbecco
MEM (GIBCO Laboratories) containing 2 g of
NaHCO3 per liter, 4.5 g of glucose per liter, 10% FCS,
and 50 ug of gentamicin per ml. Labeled tumor cell
monolayers lysed with 0.5% sodium dodecyl sulfate
in water were used to estimate total incorporated
[3H]TdR from labeled tumor cells in duplicate or
triplicate cultures. Results are expressed as mean
counts per minute ± standard deviation.
Peritoneal cells. Peritoneal exudate cells from
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mice treated either 18 to 24 h previously with 1 ml of
phosphate-buffered saline or 7 days previously with 2
X 10 colony-forming units of viable BCG organisms
intraperitoneally were collected after intraperitoneal
injection of 8 to 10 ml of Dulbecco MEM as described
elsewhere (25). This medium contained 2 g ofNaHCO3
per liter, 4.5 g of glucose per liter, 10% FCS, and 50 Ig
of gentamicin/ml. Peritoneal fluid was withdrawn
through the anterior abdominal wall with a 19-gauge
needle. Fluids from 3 to 10 mice were pooled, a sample
was taken for differential and total cell counts, and the
remainder was centrifuged in polypropylene tubes (no.
2074, Falcon Plastics) at 250 X g for 10 min at 4VC.
Differential counts were made on Wright-stained cell
smears prepared by cytocentrifugation (Cytospin cen-
trifuge, Shandon Southern Instruments, Camberley,
England). Washed peritoneal exudate cell suspensions
from each pool of mice were adjusted to equal mac-
rophage concentrations in Dulbecco MEM containing
2 g of NaHCO3 per liter, 4.5 g of glucose per liter, 10%
FCS, and 50 jig of gentamicin per ml.
Spleen cells. Spleens were aseptically removed and
passed through 50-mesh stainless-steel sieves into cul-
ture medium (RPMI 1640 with 50 ytg of gentamicin per
ml, GIBCO). Single-cell suspensions obtained by serial
aspirations through 19- and 23-gauge needles were
treated with 2:1 (vol/vol) lysing buffer (0.16 M NH4Cl,
0.01 M KHCO3, 10-4 M disodium ethylenediaminetet-
raacetate, pH 7.4) for 1 to 2 min to lyse erythrocytes.
Spleen cells were centrifuged at 250 x g for 10 min at
4VC and resuspended in the same medium as the
peritoneal exudate cells.
Adherent cell populations of either spleen or peri-
toneal exudate cells were obtained by allowing the
cells to adhere to plastic for 2 h at 370C and then
removing the nonadherent cells by washing three
times with medium.
PU 6-1.8 cell line. The PU 5-1.8 cell line derived
from a spontaneous tumor in a BALB/c mouse (20)
was kindly provided by R. Aksamit and S. Mizel
(National Institutes of Health, Bethesda, Md.), who
also provided the P 388 DI cells. The cells were grown
in Eagle MEM with 10% FCS and 50 jg of gentamicin
per ml with a doubling time of 16 to 20 h. Cells were
detached by scraping them offwith a rubber policeman
and were suspended in the same medium as the peri-
toneal exudate cells.
In vitro-propagated macrophages. L 929 cell-
conditioned medium was used as a source of macro-
phage growth factor (colony-stimulating factor) to
propagate macrophages from peritoneal exudate pre-
cursor cells (30). Peritoneal exudate cells from C3H/
HeN mice taken 3 days after intraperitoneal injection
of 2 ml of thioglycolate broth (Media Production Unit,
National Institutes of Health, Bethesda, Md.) were
suspended in enriched McCoy 5A medium (Media
Production Unit) at 2,500 cells per ml. Amounts of 2
ml of cell suspension were added to 35-mm plastic
tissue culture dishes (no. 3001, Falcon Plastics) and
incubated at 37°C for 2 h. Nonadherent cells were
washed off, and 2 ml of fresh medium containing 15%
FCS and L-cell-derived macrophage growth factor at
optimal concentrations was added. After 2 weeks of
incubation, the cell number per culture had increased
approximately 100-fold. As judged by microscopic ex-
amination of Wright-stained cultures, and by phago-
cytosis of latex beads and antibody-coated sheep
erythrocytes, the cultured cells were greater than 99%
macrophages.
Antisera. Female rabbits (New Zealand white)
were obtained from the Division of Research Services,
National Institutes of Health. The animals were in-
jected with serum-derived tumor cytotoxic factor par-
tially purified on Sephacryl S-200 and diethylamino-
ethyl-Sephacel (Pharmacia Fine Chemicals, Inc.) in
complete Freund adjuvant or with equivalent fractions
from serum of control mice injected intravenously
with 10 jig of LPS 2 h before exsanguination (control
serum). Antigen preparations contained about 25 mg
of protein per injection. The animals were boosted
with the same antigen preparation subcutaneously in
complete Freund adjuvant twice, after 3 weeks and
after 8 weeks, and later periodically with antigen with-
out Freund adjuvant. The rabbits were bled from the
ear artery, and the serum was prepared. The sera were
heat inactivated (30 min at 56°C), and proteins were
precipitated with 50% saturated ammonium sulfate.
The precipitate was dissolved and extensively dialyzed
in phosphate-buffered saline. The titer for a 50% in-
hibition ofa 1:1,000 dilution ofserum cytotoxic activity
for the antiserum used in this study was 320.
Chromatographic procedures. Samples were
subjected to gel filtration on a Sephacryl S-200 column
(2.6 by 90 cm) equilibrated in pH 7.5 buffer containing
0.05 M tris(hydroxymethyl)aminomethane and 1.6 M
sodium chloride. All chromatographic procedures were
performed at 4°C at a flow rate of approximately 12
ml/h. Samples (3 ml) of supernatants were applied to
the column. Fractions of approximately 3 ml were
collected, and samples were sterilized by membrane
filtration before they were tested in the cytotoxicity
assay. Samples (3 ml) of supernatants were applied on
a column of diethylaminoethyl-Sephacel (1.5 by 30
cm) equilibrated in 0.05 M tris(hydroxymethyl)-
aminomethane buffer, pH 7.1. The column was washed
with four column volumes of starting buffer prior to
initiation of a linear 0 to 400 mM sodium chloride
gradient (total gradient volume, 280 ml). The flow rate
was approximately 13 ml/h. Fractions (3 ml) were
collected, and samples were prepared for the cytotox-
icity assay. The sodium chloride content of the column
fractions was determined with an osmometer (model
3L, Advanced Instruments, Inc., Newton Highlands,
Mass.)
Buffers. Buffers used for testing the pH stability of
cytotoxic factors were 0.1 M glycine buffer, pH 2 and
3; 0.1 M citrate buffer, pH 4; 0.2 M acetate buffer, pH
5; 0.1 M phosphate buffer, pH 6 and 7; 0.1 M
tris(hydroxymethyl)aminomethane buffer, pH 8; and
0.1 M borate buffer, pH 9 and 10. All buffers contained
0.1 M sodium chloride.
RESULTS
Release of tumor cytotoxic activity from
macrophages obtained from BCG-infected
mice. Tumor cytotoxic activity was detected in
the serum of BCG-infected mice after LPS chal-
lenge (4, 13). To determine the cellular source of
this cytotoxin, we cultured cells obtained from
different organs of normal and BCG-infected
mice. Equal numbers of either the unfraction-
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ated spleen or peritoneal exudate cell population
or the adherent fraction of peritoneal exudate
cells were incubated with different quantities of
LPS for 2 h (Table 1). The supernatant of cells
from BCG-infected mice cultured with 100 pg or
more of LPS per ml consistently contained tu-
moricidal activity. As demonstrated in Table 1,
peritoneal exudate cells or adherent peritoneal
exudate cells from BCG-infected mice required
less LPS (10 pg/ml) for liberation of cytotoxic
factor than did the spleen cells. No cytotoxin
release over background level was detected when
the cells were cultured without LPS. Also, peri-
toneal exudate cells and spleen cells from normal
control mice did not produce detectable levels
of cytotoxic activity when cultured with 0 to 1
Atg of LPS per ml. Furthermore, supernatants
containing LPS did not exert any direct cyto-
toxic effect on the target cells (14).
Different numbers of adherent peritoneal ex-
udate cells and nonadherent spleen cells (less
than 10% macrophages by morphology) were
cultured with 10 ng of LPS per ml for 2 h to
determine whether the release of the cytotoxin
was dependent upon the number of adherent
cells (Fig. 1A). Cytotoxic activity increased with
increasing cell numbers. The influence of non-
adherent cells was estimated by culturing a con-
stant number of cells containing various per-
centages of adherent cells. Figure 1B shows a
linear dependency of production of tumor cyto-
toxic activity on the number of adherent cells
cultured in the presence of LPS. This suggests
that the macrophages are the secretary cells for
the tumoricidal activity since the nonadherent
cells do not produce the cytotoxin.
Cytotoxic aefivity was maximal after 2 to 3 h
and decayed thereafter (Fig. 2A). When the me-
TABLE 1. Tumor cytotoxic activity from different cell populations ofnormal and BCG-infected mice
Spleen cells Peritoneal exudate cells Adherent peritoneal exudate cells
LPSa
Nonnal BCG Normal BCG Nonnal BCG
0 530 20b 670 + 110 430 ± 20 740 ± 20 530 ± 80 520 ± 70
1 pg 480 ± 10 720 ± 20 NT 900 ± 10 NT 800 ± 10
10pg 470 ± 70 780 ± 10 NT 1,400 ± 90 NT 1,010 ± 40
100 pg 560 ± 70 1,150 ± 20 NT 1,400 ± 90 NT 1,750 ± 200
1 ng 630 ± 20 1,660 ± 120 660 ± 10 1,540 ± 110 660 ± 20 2,050 ± 60
10 ng 650 ± 20 1,840 ± 170 830 ± 20 1,700 ± 110 790 ± 80 1,860 ± 10
100ng 850 ± 10 1,800 ± 100 670 ± 20 1,800 ± 70 660 ± 10 1,910 ± 10
1 Ug 800 ± 30 1,800 ± 50 640 ± 10 1,580 ± 200 750 ± 10 1,880 ± 200
'Cells (106/ml) from normal or BCG-infected mice were incubated in the presence of E. coli K235 LPS for
2 h.
b Tumor cytotoxicity of the 1:2 diluted cell-free supernatants was estimated by [3H]TdR release of labeled L
929 cells at 48 h (counts per minute ± standard deviation; total incorporated cpm = 25 x 102; spontaneously
released cpm = 500 ± 30). NT, not tested.
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FIG. 1. Determination of tumor cytotoxic activity from LPS-challenged adherent peritoneal exudate cells
(PEC) or nonadherent spleen cells from BCG-infected mice. Increasing numbers of adherent PEC or
nonadherent spleen cells (A) or a mixture of both cell types (B) were cultured with E. coli K235 LPS (10 ng/ml)
for 2 h. Cytotoxic activity of the 1:2 diluted cell-free supernatant was estimated by [3H]TdR release from
labeled L 929 cells at 48 h (total incorporated cpm = 43 x 103).
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A dium containing LPS was replaced at hourlyBCG-Activated intervals and tested for cytotoxic activity, no
3 Macrophages significant decrease could be found after 3 h. On
the other hand, supernatant from cultures stim-
ulated with LPS 3 h earlier but collected after
21 h expressed no cytolytic activity. The super-
2 natant obtained at this later time (pH greater
than 6.8) significantly inhibited the cytotoxic
activity of a 3-h supernatant in a dose-dependent
fashion (50% inhibition at a 1:2 dilution of the
1!-4 / T supernatant collected at the later time). Control
-- -2 ---- supernatant from unstimulated cultures, how-
ever, had the same inhibitory capacity. The
cytotoxic activity was not absorbed from the
medium by spleen cells, peritoneal exudate cells,
or fibrosarcoma cells. The cytotoxic activity
when removed from the cell culture was stable
10 - B T ~ at 370C but was lost when treated with protease,
Macropaed trypsin, or chymotrypsin (data not shown). This
6 8 I \ suggests that a soluble factor(s) or an enzyme(s)
x_ / \is released from the activated as well as the
nonactivated cells after 3 h of incubation, which
inactivates the cytotoxic activity.
Release of tumor cytotoxic factor from
macrophage cultures propagated with
z4 - ,; macrophage growth factor. More homoge-
us -1neous macrophage cultures were obtained by
!5 2' / propagating thioglycolate-induced peritoneal ex-
udate cells with mouse L 929 cell supernatant
I F~~~~+~~~~+ +____+____+____* containing macrophage growth factor (11, 30).
,_____,_____,_________________,____ Within 13 to 14 days of culture, the cells had
multiplied about 100-fold and the population
2D C consisted of over 99% macrophages, as deter-20 C PU 5 - 1.8 mined by morphology and uptake of latex beads
or antibody-coated sheep erythrocytes. When
these cells were stimulated with different quan-
15 - tities of LPS, they were extremely sensitive to
LPS in terms of cytotoxin release (Table 2).
Picogram quantities of LPS were sufficient to
10 / induce soluble cytotoxic activity. Kinetics fordetection of the cytotoxin in the supernatant
(Fig. 2B) show the same pattern as for serum-
derived tumor cytotoxic activity (14) or cyto-
5 - / toxic factor from peritoneal exudate cells of
-----a-+----____ BCG-infected mice challenged in vitro with LPS
(Fig. 2A).
i_____,_____,____,_____,_____,___ Release of tumor cytotoxic factor from
1 2 3 4 5 6 the macrophage-like cell line PU 5-1.8. Re-
HOURS OF INCUBATION cently, several mouse monocyte/macrophage tu-
FIG. 2. Kinetics ofappearance ofcytotoxic activity mor cell lines have been described which differ
from LPS-challenged adherent peritoneal exudate in the properties they share with blood mono-
cells (PEC) of BCG-infected mice, cultured macro- cytes or peritoneal macrophages. The tumor line
phages propagated in the presence of macrophage PU 5-1.8 has the ability to phagocytize, bears
growth factor for 14 days, and PU 5-1.8 cells. Adher-
ent PEC (106/ml) of BCG-infected mice (A), cultured
macrophages (0.3 x 106/ml) (B), and PU 5-1.8 cells estimated by [3H]TdR release of labeled L 929 cells
(1.3 x 106/ml) (C) were incubated for different periods at 48 h (total incorporated cpm for the experiment
of time with E. coli K235 LPS (10 ng/ml). Cytotoxic shown in panel A = 12 x 102, panel B = 30 x 102, and
activity of the 1:2 diluted cell-free supernatants wes panel C = 24 x 102).
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TABLE 2. Tumor cytotoxic activity from
macrophage cultures propagated with macrophage
growth factora
LPSb (ng) Label releasec
0 180 + 10
0d 190+ 30
0.1 1,080 + 40
1 930 + 10
10 970±90
100 1,020 ± 170
1,000 1,000± 60
a Propagated macrophages were obtained by cultur-
ing peritoneal exudate cells in the presence of macro-
phage growth factor for 14 days.
b Propagated macrophages (3 X 105 cells per ml)
were incubated in the presence of E. coli K235 LPS
for 2 h.
'Tumor cytotoxicity of the 1:2 diluted cell-free su-
pernatants was estimated by [3H]TdR release of la-
beled L 929 cells at 48 h (counts per minute ± standard
deviation; total incorporated cpm = 30 x 102; sponta-
neously released cpm = 70 ± 10).
d Reconstituted with 1,000 ng of LPS.
receptors for immunoglobulin and complement
(22), secretes lysozyme (21, 22), and is capable
of becoming cytolytic for tumor target cells in
the presence of specific antisera (23). These
same cells can also be activated for nonspecific
tumor cell killing (M. Meltzer, personal com-
munication). Different numbers of these PU 5-
1.8 cells were incubated for 2 h with various
concentrations ofLPS and tested for their ability
to release soluble cytotoxic activity (Fig. 3).
Again, the cytotoxic activity detected was de-
pendent on the cell number. The concentration
of LPS required to induce the cytotoxin release
was in the nanograms per milliliter range. The
kinetics of appearance of cytotoxic activity
reached maximal levels after 2 to 3 h (Fig. 20).
In contrast, cells of another macrophage-like
tumor cell line, P 388 Di, did not release any
cytotoxic factor when cultured with different
concentrations of LPS for various periods of
time (data not shown).
Physicochemical characteristics of tu-
mor cytotoxic activities from LPS-stimu-
lated cultures. The physicochemical charac-
teristics of the cytotoxic activities induced by
LPS in macrophage-enriched or macrophage-
like cultures were compared with those of the
serum-derived tumor cytotoxic factor. When ap-
plied to diethylaminoethyl-Sephacel columns at
pH 7.1, the in vitro-generated cytotoxins from
all three sources were retained; they eluted in a
sodium chloride salt gradient at 200mM sodium
chloride. Figure 4 shows a representative elution
profile obtained with the cytotoxic activity from
LPS-treated and BCG-activated macrophages.
The apparent molecular weights estimated by
gel filtration on Sephacryl S-200 were similar for
all three cytotoxic factors. The activity eluted in
a broad peak in the molecular weight range of
50,000 to 60,000 (Fig. 5). The cytotoxins were
stable for 30 min at 56°C but completely de-
stroyed after 10 min at 100°C (Table 3). The pH
sensitivity of cytotoxic factor from serum was
compared with that of cytotoxic factor from
BCG-activated macrophages stimulated in vitro
with LPS (Table 4). In both cases cytotoxic
activity was stable at pH 6 to 10 but was lost
when held below pH 6.
A rabbit antiserum raised against serum-de-
rived cytotoxic factor inhibited the cytotoxic
activities derived from all macrophage sources
(Table 5). Control serum exhibited only a slight
inhibitory effect which was not observed when
purified immunoglobulin G was used (data not
shown).
DISCUSSION
Macrophages secrete a variety of products
that lyse tumor target cells (1-3, 5, 6, 8, 10, 16,
18, 19, 24, 27, 28, 31). In some cases the chemical
nature of these cytotoxins has been character-
ized. Arginase (6), hydrogen peroxide (18), or
seine proteases (1) are released by properly
activated macrophages and induce tumor cell
death. None of the substances mentioned above
appears to be the active principle in the cyto-
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FIG. 3. Determination of tumor cytotoxic activity
from LPS-challenged PU 5-1.8 cells. Different num-
bers ofPU 5-1.8 cells were incubated in the presence
of E. coli K235 LPS for 2 h. Cytotoxic activity of the
1:2 diluted cell-free supernatants was estimated by
[3H]TdR release of labeled L 929 cells at 48 h (total
incorporated cpm = 34 x 102).
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toxic factor described in this communication.
The activity ofthe cytotoxin was lost after treat-
ment with protease, trypsin, and chymotrypsin,
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FIG. 4. Diethylaminoethyl-Sephacel chromatog-
raphy of tumor cytotoxic supernatant from BCG-ac-
tivated peritoneal exudate cells. A 3-ml amount of
supernatantfrom BCG-activated adherentperitoneal
exudate cells (106/ml) incubated in the presence ofE.
coli K235 LPS (10 ng/ml) for 2 h was applied on a
column ofDEAE-Sephacel (1.5 by 30 cm) equilibrated
in 0.05 M tris(hydroxymethyl)aminomethane buffer
(pH 7.5). The column was washed with four column
volumes of starting buffer prior to initiation of a 0 to
400 mM sodium chloride gradient (total gradient
volume, 280 ml). The flow rate was approximately 13
ml/h. Fractions (3 ml) were collected and sterile
filtered. Tumor cytotoxic activity of a 1:4 dilution of
the fractions was estimated by [3H]TdR release of
labeled L 929 cells at 48 h (total incorporated cpm =
25 x 102). The molarity of the fractions was deter-
mined with an osmometer.
but was unaltered by the serine esterase inhibi-
tor diisopropyl fluorophosphate (data not pre-
sented).
The soluble cytotoxic activities obtained from
adherent peritoneal exudate cells of BCG-in-
fected mice, from in vitro-propagated macro-
phages, or from PU 5-1.8 cells share many char-
acteristics with the previously described serum-
derived cytotoxic factor (14). In all four systems,
the inducing stimulus, LPS, was effective in
minute (nanogram) quantities. Optimal levels of
cytotoxicity were detected after 2 to 3 h. The
macrophages were stimulated by BCG, by cul-
tivation in macrophage growth factor-containing
medium, or as a result of characteristics of the
tumor cell line. Behavior on ion-exchange and
gel filtration columns and heat stability of the in
vitro-generated cytotoxins were very similar to
TABLE 4. pH sensitivity of tumor cytotoxic activities
from different sources
pH Cytotoxic seruma Propagated macro-phages'
2 130 ± 70b 320 ± 20
3 100± 10 330±20
4 170 ± 10 330 ± 10
5 220±30 450 ± 10
6 1,940 ± 190 1,120 ± 40
7 1,710 ± 200 1,180 ± 90
8 1,890 ± 130 1,230 ± 30
9 1,960 ± 60 1,080 ± 50
10 1,940 + 80 860 ± 20
Samples of pooled serum-derived cytotoxic activ-
ity chromatographed on a Sephacryl S-200 column (1:
100 dilutions) or samples of cytotoxic supernatant (1:
4 diluted) from macrophages propagated in the pres-
ence of macrophage growth factor for 14 days were
dialyzed in buffers of different pH levels for 18 h and
then dialyzed in phosphate-buffered saline until the
pH was stable.
b Tumor cytotoxicity of the serum-derived samples
and of supernatant samples was estimated by [3H]-
TdR release of labeled L 929 cells at 48 h (counts per
minute ± standard deviation; for cytotoxic serum, total
incorporated cpm = 35 x 102 and spontaneously re-
leased cpm = 160 ± 10; for cultured macrophage
supernatant, total incorporated cpm = 20 x 102 and
spontaneously released cpm = 310 ± 60).
TABLE 3. Heat sensitivity of tumor cytotoxic activities from different sources
BCG-activated
Treatment Cytotoxic serum peritoneal exudate PU 5-1.8 Propagated macro-
cellspags
None 1,800 ± 50b 900 ± 100 700 10 1,200 ± 10
30 min, 56-C 1,700 ± 50 750 ± 80 400 20 1,000 ± 100
10 min, 100°C 100 ± 30 150 ± 10 150 10 150 ± 20
a Propagated macrophages were obtained by culturing peritoneal exudate cells in the presence of macrophage
growth factor. for 14 days.
b Tumor cytotoxicity of 1:100 diluted cytotoxic serum or 1:2 diluted supernatants was estimated by [3H]TdR
release of labeled L 929 cells at 48 h (counts per minute ± standard deviation; total incorporated cpm = 30 x
102; spontaneously released cpm = 100 ± 30).
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TABLE 5. Cross-reactivity of tumor cytotoxic activities from different sources with a rabbit antiserum
Treatment Cytotoxic serum BCG-activated peri- PU 5-1.8 Propagated macro-toneal exudate cells phagesa
None 2,100 ± 100b 2,400 ± 100 1,100 ± 10 1,600 ± 50
Control serunc 1,400 ± 100 2,200 ± 100 800 ± 50 1,300 ± 30
Antiserum' 200 ± 30 300 ± 10 100 ± 30 500 ± 20
a Propagated macrophages were obtained by culturing peritoneal exudate cells in the presence of macrophage
growth factor for 14 days.
b Tumor cytotoxicity of 1:1,000 diluted cytotoxic serum or 1:2 diluted supernatants was estimated by [3H]
TdR release of labeled L 929 cells at 48 h (counts per minute ± standard deviation; total incorporated cpm = 30
x 102; spontaneously released cpm = 80 ± 10).
¢ Rabbit sera were heat activated (30 min at 560C), precipitated with ammonium sulfate (50% saturation) and
added to the cytotoxicity assay in a final concentration equivalent to 1/80 of the original serum.
§ those of serum cytotoxin. Inhibition of the cy-
totoxic activities was achieved with a rabbit
i r~~~~~~antiserum directed against the serum cytotoxic
7<4 factor. The cytotoxic activity found in serum of
+ ici aBCG-infected mice after LPS injection was un-
stable below pH 6, as was the cytotoxin from
BCG-activated macrophages. If, indeed, the se-
3 m11 rum-derived cytotoxic factor which we previ-
ously studied (14) is identical to TNF, then the
tumoricidal factor from cultured macrophages is
probably TNF. Matthews described the spon-
taneous release of TNF from rabbit blood mon-
ocytes in vitro (12). This cytotoxic activity
clearly differs in mode of production and physi-X cochemical properties from the murine cytotoxin
dealt with in the present report. However, ob-
u 2 - \ training direct proof that the in vitro-generated
cytotoxic activity has tumor-necrotizing activity
may not as yet be feasible because the in vivo
UJ assay requires large volumes of TNF-containing
W serum (4).
cc ; b 1Recent studies have demonstrated that the
UI\ development of tumoricidal macrophages re-
co Bull squires several activation signals (25, 26, 32). In
5 1 - , /[ Jz \ a similar manner, release ofthe soluble cytotoxin
from macrophages also required more than one
stimulus, which suggests that this cytotoxin may
be involved in the mechanism of macrophage
tumor cell destruction. The lack of LPS dose-
response effect in eliciting soluble cytotoxic ac-
tivity (Table 2) implies that LPS acts in a trigger
mode rather than as a primary stimulus on
i properly activated macrophages.
50 70 90 110 Several studies demonstrate that macrophage
FRACTION NUMBER tumor cell killing is dependent upon effector-FR.pACTIS 0ONNUMBER target cell contact (7, 17, 29). It can be hypoth-
FIG. 5. Sephaciyl S-2( chromatography of tumor esized that the cytotoxin herein described is
cytotoxic supernatant from BCG-activatedperitoneal labile in the presence of proteases and conse-
exudate cells. A 3-ml amount of supernatant from quently that high concentrations are only ob-
BCG-activated adherent peritoneal exudate cells tainted within the region of cell-cell contact. Ac-(106/ml) incubated in the presence of E. coli K235 tivated macrophages could carry this cytotoxinLPS (10 ng/ml) for 2 h was applied to a Sephacryl S-
200 column. The column was 2.6 by 90 cm, and the
flow rate was approximately 12 ml/h. The column activity of 1:4 dilutions of the 3-ml sterile filtered
was equilibrated and elated with 0.05 M fractions was estimated by [3HJTdR release of la-
tris(hydroxymethyl)aminomethane buffer (pH 7.5) beled L 929 cells at 48 h (total incorporated cpm = 14
containing 0.1 M sodium chloride. Tumor cytotoxic x 102).
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inserted in the membrane and might liberate it
into the medium only when stimulated with
inflammatory substances such as LPS. In fact,
preliminary results show that an antiserum di-
rected against the cytotoxic factor partially in-
hibits tumor cell killing by BCG-activated mac-
rophages cultured with LPS. This supports the
concept that this cytotoxin plays a central role
in tumor cell killing by these cells.
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